Last reviewed · How we verify

NCT06362200

The Validation and Biological Index Studies on the Improved Social Function of ASD by 40 Hz tACS

Completed NA Last updated 10 June 2025
What this trial tests

NA trial testing 40 Hz tACS intervention in Autism Spectrum Disorder in 47 participants. Completed in 13 February 2025.

Timeline
7 April 2024
Primary endpoint
13 February 2025
13 February 2025

Quick facts

Lead sponsorCentral South University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment47
Start date7 April 2024
Primary completion13 February 2025
Estimated completion13 February 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Central South University

Who can join

Adults 6 to 18, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this proposed study, tACS will be used to intervene in the autism spectrum disorders of children and adolescents, and the efficacy of this intervention method will be evaluated, as well as the internal mechanism of adolescents' autism spectrum disorders will be discussed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other Central South University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06362200.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing